Olmesartan potentiates the anti-angiogenic effect of sorafenib in mice bearing Ehrlich's ascites carcinoma: role of angiotensin (1-7)
about
Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis.Uncommon presentation of potential medication-related osteonecrosis of the jawBoswellic acids synergize antitumor activity and protect against the cardiotoxicity of doxorubicin in mice bearing Ehrlich's carcinoma.Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy.Liver Protective Effects of Renin-Angiotensin System Inhibition Have No Survival Benefits in Hepatocellular Carcinoma Induced By Repetitive Administration of Diethylnitrosamine in Mice.
P2860
Olmesartan potentiates the anti-angiogenic effect of sorafenib in mice bearing Ehrlich's ascites carcinoma: role of angiotensin (1-7)
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Olmesartan potentiates the ant ...... oma: role of angiotensin (1-7)
@en
Olmesartan potentiates the ant ...... carcinoma: role of angiotensin
@nl
type
label
Olmesartan potentiates the ant ...... oma: role of angiotensin (1-7)
@en
Olmesartan potentiates the ant ...... carcinoma: role of angiotensin
@nl
prefLabel
Olmesartan potentiates the ant ...... oma: role of angiotensin (1-7)
@en
Olmesartan potentiates the ant ...... carcinoma: role of angiotensin
@nl
P2860
P1433
P1476
Olmesartan potentiates the ant ...... oma: role of angiotensin (1-7)
@en
P2093
Soad H Abou-El-Ela
Yasser M Moustafa
P2860
P304
P356
10.1371/JOURNAL.PONE.0085891
P407
P577
2014-01-22T00:00:00Z